塑造呼吸照护的未来:未来十年展望与EUFOREA战略建议
2025年4月EUFOREA在布鲁塞尔举办十周年研讨会,聚焦哮喘、慢阻肺、慢性鼻窦炎和呼吸过敏等慢性呼吸疾病负担。会议提出向预测性、预防性和以患者为中心的医学模式转变,并支持价值导向的医疗体系以改善患者长期结局。本报告总结了会议主要见解与战略方向。
要点
- 慢性呼吸疾病仍为全球可预防疾病和残疾的主要原因之一。
- 2025年西方人群慢性呼吸疾病患病率可达三分之一。
- 战略重点为预测性、预防性和以患者为中心的医学及价值导向医疗。
核心结论
- 研讨会强调向预测性、预防性和以患者为中心的医学转变,并支持价值导向的医疗体系以改善长期患者结局。
研究设计与样本
- EUFOREA于2025年4月在布鲁塞尔举办十周年研讨会,邀请世界卫生组织与EUFOREA主旨讲者,总结会议见解与战略方向。
主要发现
- 慢性呼吸疾病仍为全球可预防疾病和残疾的主要原因之一。
- 2025年西方总人口中慢性呼吸疾病患病率可达三分之一。
- 会议关注哮喘、慢阻肺、慢性鼻窦炎和呼吸过敏等炎症性气道疾病的沉重负担。
关键数值与推荐
- 会议目标包括促进创新转化为日常临床实践的对话、鼓励呼吸领域不同利益相关方合作、定义未来十年转变呼吸照护并遏制慢性呼吸疾病流行的战略优先事项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic respiratory diseases (CRDs) remain 1 of the leading causes of preventable morbidity and disability worldwide, affecting up to one-third of the total Western population in 2025. Recognizing the substantial burden of inflammatory airway diseases such as asthma, COPD, chronic rhinosinusitis, and respiratory allergy, the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) organized the symposium "Shaping the Future of Respiratory Care" in April 2025 in Brussels, Belgium, at the occasion of the 10-year jubilee. Featuring keynote speakers from the World Health Organization and EUFOREA, this initiative had the following aims: (1) promoting dialogue on translating innovations into daily clinical practice; (2) encouraging collaboration between the different stakeholders in the respiratory field; and (3) defining strategic priorities to transform respiratory care and arrest the CRD epidemic over the next decade. The symposium highlighted the importance of moving toward predictive, preventive, and patient-centered medicine, while supporting value-based health care systems to improve long-term patient outcomes. This report summarizes the main insights and strategic directions discussed at the meeting.
引用
- Bertels, Scadding, Backer, et al. Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by the European Forum for Research and Education in Allergy and Airways Diseases. Chest. 2026. PMID: 41544956. doi:10.1016/j.chest.2025.12.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。